A study reveals that administering a single dose of ketamine - a drug commonly used as general anesthetic or a rapid-acting antidepressant - one week before a stressful event, can buffer against a heightened fear response and may also prevent post-traumatic stress disorder (PTSD) symptoms.
Researchers from Columbia University Medical Center (CUMC) in the U.S., conducted the study on mice and suggested that prophylactic administration of ketamine may help soldiers and others who subsequently experience psychological trauma.
The study appeared online in the journal Neuropsychopharmacology.
"Ketamine is a powerful drug and we wouldn't advocate widespread use for preventing or reducing PTSD symptoms. But if our results in mice translate to humans, giving a single dose of ketamine in a vaccine-like fashion could have great benefit for people who are highly likely to experience significant stressors, such as members of the military or aid workers going into conflict zones," said study author Christine A. Denny.
PTSD symptoms include re-living a trauma - experiencing repeated flashbacks, hyperarousal and hyperreactivity - as well as mood changes, psychological numbing and chronic physical symptoms such as headache.
For the research, the mice were given a small dose of intravenous ketamine or a placebo either one month, one week, or one hour before they were subjected to a series of small shocks.
Only the mice given ketamine one week before the stressor, exhibited reduced freezing when they were returned to the test environment.
"Our findings indicate that the timing of ketamine administration is critical for buffering fear expression," said first author Josephine C. McGowan.
They also found that giving ketamine immediately after the stressor did not affect the animals' fear response.
However, giving ketamine one hour after a second shock, decreased the expression of fear, suggesting that there may be another potential window after the initial trauma when the drug may be effective.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
